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Summary
Creutzfeldt-Jakob disease (CJD) belongs to a group of
prion diseases that may be infectious, sporadic, or he-
reditary. The 200K point mutation in the PRNP gene is
the most frequent cause of hereditary CJD, accounting
for 170% of families with CJD worldwide. Prevalence
of the 200K variant of familial CJD is especially high in
Slovakia, Chile, and Italy, and among populations of
Libyan and Tunisian Jews. To study ancestral origins of
the 200K mutation–associated chromosomes, we se-
lected microsatellite markers flanking the PRNP gene on
chromosome 20p12-pter and an intragenic single-nucle-
otide polymorphism at the PRNP codon 129. Haplo-
types were constructed for 62 CJD families originating
from 11 world populations. The results show that Lib-
yan, Tunisian, Italian, Chilean, and Spanish families
share a major haplotype, suggesting that the 200K mu-
tation may have originated from a single mutational
event, perhaps in Spain, and spread to all these popu-
lations with Sephardic migrants expelled from Spain in
the Middle Ages. Slovakian families and a family of Po-
lish origin show another unique haplotype. The hap-
lotypes in families from Germany, Sicily, Austria, and
Japan are different from the Mediterranean or eastern
European haplotypes. On the bais of this study, we con-
clude that founder effect and independent mutational
events are responsible for the current geographic distri-
bution of hereditary CJD associated with the 200K
mutation.
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Introduction
Creutzfeldt-Jakob disease (CJD; MIM 123400) is a rap-
idly progressive neurodegenerative disorder character-
ized by prominent dementia, cerebellar ataxia, rigidity,
pyramidal signs, myoclonus, and paroxysmal bursts of
high-voltage waves on electroencephalogram (Brown et
al. 1994). Spongiform degeneration, neuronal loss, and
astrocytic gliosis are the major neuropathologic features
(Beck and Daniel 1987). The disease typically affects
middle-aged individuals and leads to death within 6–24
mo after onset. CJD is randomly distributed worldwide
with a yearly incidence rate of ∼1/1,000,000 (Brown et
al. 1986). From 5% to 10% of CJD cases show a familial
pattern corresponding to autosomal dominant inheri-
tance (Masters et al. 1979; Brown et al. 1994). Brain
suspensions of patients with CJD, including patients
with familial CJD, transmit the disease to experimental
animals through intracerebral inoculation (Gibbs et al.
1968), confirming that this disorder is both hereditary
and transmissible.
The PRNP gene coding for the prion protein has been
mapped to chromosome 20p12-pter (Sparkes et al.
1986), and a number of mutations in this gene have been
associated with hereditary forms of spongiform enceph-
alopathy, familial CJD, Gerstmann-Stra¨ussler-Scheinker
disease, and familial fatal insomnia (Goldfarb and
Brown 1995).
An ArG transition in codon 200 of the PRNP coding
region changes the codon sequence from GAG to AAG
and results in a predicted substitution of lysine (200K)
for glutamate (200E) (Goldgaber et al. 1989). The 200K
mutation accounts for 170% of cases of familial CJD.
This mutation was first identified in a CJD family from
Poland (Goldgaber et al. 1989) and later in clusters of
this disease in Slovakia (Goldfarb et al. 1990c), Libyan
Jews (Goldfarb et al. 1990b; Hsiao et al. 1991), Chile
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(Brown et al. 1992), Italy (D’Alessandro et al. 1998),
and Japan (Miyakawa et al. 1998). The annual incidence
rate of CJD in some of these populations is much higher
than the world average: ∼200/1,000,000 in a rural pop-
ulation of Slovakia (Mitrova 1991), ∼75/1,000,000
among the Libyan Jewish migrants living in Israel (Hsiao
et al. 1991), and nearly 18/1,000,000 in central Chile
(Galvez et al. 1980). Familial CJD associated with the
200K mutation has also been described in Tunisian and
Greek Jews (Goldfarb et al. 1990a; Brown et al. 1991)
and in non-Jewish groups in Spain (Coria et al. 1995),
Britain (Collinge et al. 1993; Windl et al. 1996), and
Austria (Hainfellner et al. 1996). Genetic linkage be-
tween the 200K mutation and familial CJD was estab-
lished in genetic studies of this disease in Libyan Jews
(Gabizon et al. 1993).
Analysis of worldwide distribution of the 200K CJD
variant (Goldfarb et al. 1991) led to an early hypothesis
that the 200K mutation originated in Spain and spread
to Mediterranean countries and South America with a
massive migration that resulted from the expulsion of
Sephardic Jews. This hypothesis was supported by the
finding that in all these populations the 200K mutation
is coupled with 129M at the PRNP polymorphic codon
129, which has a variable M/V ratio in different pop-
ulations. However, this hypothesis was disputed on the
basis of other aspects of history (Gabizon et al. 1993;
Korczyn 1994). A considerable number of Sephardic
Jews emigrated to Turkey and the Netherlands. Those
who came to the Netherlands soon intermarried with
Ashkenazi Jews, but the 200K mutation has not been
found in Sephardic Jews of Turkey or among Ashkenazi
Jews in the Netherlands, England, or other western Eur-
opean countries to which Dutch Jews have emigrated.
In addition, there has been a close interconnection be-
tween the Jewish communities of Libya, Tunisia, Greece,
and France (Meiner et al. 1997), but it seems unlikely
that Jewish people would intermarry with Slovaks or
Chileans (Korczyn 1994). With the purpose of estab-
lishing ancestral origins of the 200K mutation, we se-
lected highly polymorphic microsatellite markers flank-
ing the PRNP gene on chromosome 20p12-pter and an
intragenic single-nucleotide polymorphism to analyze
the 200K mutation–associated haplotypes in 62 families
representing 11 world populations.
Families and Methods
CJD Families and Controls
Sixty-two families segregating CJD with the 200K mu-
tation, including 15 Libyan Jewish, 6 Tunisian Jewish,
6 Italian, 6 Chilean, 23 Slovakian, 1 Spanish, 1 Polish,
1 Japanese, 1 German, 1 Sicilian, and 1 Austrian, were
selected for this study. These families represent all major
countries/populations in which the 200K variant of fa-
milial CJD has been reported. Two or more family mem-
bers were available for testing in 35 studied families.
One of the Libyan subjects was homozygous for the
200K mutation. Unaffected healthy controls included 41
individuals of Libyan Jewish and 92 of Slovakian origin.
Genotypes of French reference samples were also ana-
lyzed (CEPH database).
Screening for the 200K Mutation and the 129M/V
Polymorphism
The GAGrAAG change at PRNP codon 200 abol-
ishes a BsmA1 restriction site ([N]5GAGAC), providing
an easy technique to screen for this mutation (Goldfarb
et al. 1990a). The ATG/GTG polymorphism at codon
129, coding for methionine or valine (M/V), is also con-
veniently determined by restriction analysis with endo-
nuclease MaeII (Goldfarb et al. 1989). In all studied
subjects, the coding region of the PRNP gene was am-
plified in a total volume of 10 ml with 50 ng genomic
DNA; 1.75 mM MgCl2; Perkin-Elmer PCR buffer (10
mM Tris-HCl [pH 8.3] and 50 mM KCl); 0.8 mM each
primer, foward (5′-ATGCTGGTTCTCTTTGTGGCC-
3′) and reverse (5′-GAAAGAGATCAGGAGGATCAC-
3′); 250 mM each dNTP; and 0.3 U AmpliTaq DNA
polymerase (Perkin-Elmer). PCR was performed in a
9600 GeneAmp thermocycler (Perkin-Elmer) under the
following conditions: 95C for 5 min, followed by 35
cycles of 94C for 30 s, 60C for 30 s, and 72C for 120
s, with a final extension step of 72C for 10 min. The
amplicons subsequently were digested with MaeII or
BsmA1 (New England Biolabs) and resolved in a 2%
agarose gel (GIBCO BRL). We cloned the PCR product
using a TA cloning kit (Invitrogen) and performed re-
striction analysis when the 200 E/K 129 M/V phase
could not be determined unambiguously from the
pedigree.
Selection of Microsatellite Markers and Microsatellite
Genotyping
Polymorphic markers flanking the PRNP gene in the
20p12-pter region were selected from the comprehensive
linkage map of chromosome 20 (Center for Medical Ge-
netics). To refine the location of the microsatellite mark-
ers in relation to the PRNP gene, we analyzed seven
YAC clones (761-D-12, 894-D-11, 856-D-9, 753-G-9,
763-E-2, 938-C-2, and 898-D-9) from contig WC 20.0
(MIT Center for Genome Research). The YAC clones
were screened by PCR for the presence and location of
candidate markers (fig. 1).
The markers selected for genotyping were as follows:
telomere-D20S867 (AFMb026xh5)-2.1 cM-D20S889
(AFM234tf10), D20S116-2.7 cM-D20S482 (GATA-
51D03), PRNP (WI7784), D20S895 (AFMb352xd9),
D20S849 (AFMa217zh9)-centromere, spanning 4.8 cM.
PCR amplification of the microsatellite markers was car-
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Figure 1 Integrated genetic and physical map of the PRNP re-
gion. Location of the microsatellite markers was determined by PCR
analysis of a contig constructed of seven human YAC clones. WI7784
is the EST of the PRNP gene. Asterisk (*) denotes markers selected
for haplotyping.
ried out with 80 ng genomic DNA in a 10-ml total re-
action volume containing 2.5 mM MgCl2, Perkin-Elmer
PCR buffer (10 mM Tris-HCl [pH 8.3] and 50 mM KCl),
0.8 mM each forward and reverse primer, 250 mM each
dNTP, and 0.3 U AmpliTaq DNA polymerase (Perkin-
Elmer). The forward primers were fluorescently labeled
with one of three phosphoamidites, 6-FAM, HEX, or
TET (Research Genetics). PCR was performed in a 9600
GeneAmp thermocycler (Perkin-Elmer) under the fol-
lowing conditions: 95C for 12 min, followed by 30
cycles of 94C for 15 s, 55C for 15 s, and 72C for 30
s, with a final 10-min extension at 72C. The PCR-am-
plified fragments were mixed with a size standard (ABI
GS500 ROX) and formamide-loading buffer and were
loaded onto a 6% denaturing acrylamyde gel. We per-
formed electrophoresis at 30W for 7 h using an ABI
373A sequencer (Perkin-Elmer). The size of the amplified
microsatellite alleles was measured by GS ANALYSIS
(2.1). The number of CA or GATA repeats was deter-
mined in each tested allele and standardized by com-
parison to genotypes of the reference sample CEPH
1347-02.
Linkage Disequilibrium and Haplotype Analysis
To estimate linkage disequilibrium between marker
loci and the PRNP 200K mutation, allele frequency dis-
tributions in the disease and control chromosomes were
compared. Using SAS version 6.11 (SAS Institute, Inc.),
we applied Fisher’s exact test for a contingency2# n
table, in which n is the number of observed alleles at
each locus, with two rows representing 200K mutation
carriers and the control group. Haplotypes were con-
structed manually, on the basis of the assumption of
minimum recombination between markers. We prefered
to use unambiguous microsatellite haplotypes for anal-
ysis. To use information from the ambiguous haplotypes,
we estimated possible allele combinations using 3LO-
CUS.PAS (Long et al. 1995), on the basis of the EM
algorithm. In the sample from the individual homozy-
gous for the disease allele, only one chromosome was
included, since consanguinity was strongly suspected in
the pedigree.
Results
The Mediterranean Haplotype
Genetic maps based on linkage analysis do not provide
optimal resolution or precise ordering of markers located
in close proximity to the PRNP gene. Since such a prob-
lem may complicate haplotype analysis, we determined
the location of markers by testing seven human YAC
clones spanning the PRNP gene region on chromosome
20p12-pter (761-D-12, 894-D-11, 856-D-9, 753-G-9,
763-E-2, 938-C-2, and 898-D-9). The resulting inte-
grated map of the PRNP region (fig. 1) defines the in-
dividual location of each marker. This analysis proved
useful in selection of microsatellite markers for this
study.
The Libyan Jewish families with CJD and controls
were studied most extensively. We analyzed frequencies
of the 200K mutation–associated microsatellite alleles of
three markers closest to the PRNP gene and compared
them with allele frequencies in the background popu-
lation (table 1). The mutation-associated allele frequency
of each marker deviated significantly from the controls
( ), suggesting that the 200K mutation–P ! .021
associated chromosomes in this population are identical
by descent. Next, three-marker haplotypes were con-
structed for the Libyan Jewish families with CJD and
compared with control haplotypes (table 2). Two related
haplotypes, 20-14-18 and 20-14-19, show an outstand-
ingly high frequency among the 200K mutation–
associated chromosomes (.47 and .28). Of eight un-
ambiguous Libyan Jewish haplotypes, 20-14-18 and 20-
14-19 were found four times each. Six of seven ambig-
uous haplotypes were in agreement with one of the
above haplotypes. Since 20-14-18 and 20-14-19 hap-
lotypes share alleles at two loci, it is likely that one of
them is derived from the other, supporting the idea of a
single historic mutational event.
All six Tunisian Jewish families show an unambiguous
20-14-18 disease-associated haplotype, indicating that
patients of Tunisian Jewish descent share one of the Lib-
yan Jewish haplotypes. The haplotypes in six Italian and
six Chilean families were determined with use of a com-
puter program developed by Long et al. (1995) that al-
lows researchers to analyze ambiguous haplotypes. The
results suggest that the 20-14-18 and 20-14-19 haplo-
types combined (.33 in Italian and .43 in Chilean pop-
ulations) are significantly more common than any of the
other possible haplotypes (table 2). Although controls
for Italian and Chilean populations were not available
for this study, we assume that the frequency of the 20-
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Table 1
Microsatellite Allele Frequencies in Unambiguous Libyan Jewish and Slovakian 200K
Mutation–Associated and Control Chromosomes
Locus and Allele
Libyan 200K
Chromosomes
(n  8)
Libyan Control
Chromosomes
(n  82)
Slovakian 200K
Chromosomes
(n  18)
Slovakian Control
Chromosomes
(n  184)
D20S116:
17 .00 .00 .00 .002
18 .00 .23 .11 .30
19 .00 .07 .00 .13
20 1.00 .36 .89 .20
21 .00 .25 .00 .17
22 .00 .02 .00 .16
23 .00 .01 .00 .01
24 .00 .06 .00 .01
P!.001 P!.001
D20S482:
12 .00 .00 .00 .05
13 .00 .14 .00 .25
14 1.00 .61 .17 .38
15 .00 .15 .83 .24
16 .00 .09 .00 .07
17 .00 .01 .00 .01
P!.021 P!.001
D20S895:
18 .50 .05 .00 .03
19 .50 .37 .94 .43
20 .00 .04 .00 .03
21 .00 .15 .06 .06
22 .00 .10 .00 .07
23 .00 .22 .00 .32
24 .00 .00 .00 .03
25 .00 .07 .00 .03
P! .001 P!.001
14-18 and 20-14-19 haplotypes in the background pop-
ulations could not be significantly different from Libyan
Jewish or CEPH reference samples (table 2). The 20-14-
18 haplotype was observed unambiguously in the large
Spanish family. The consistent presence of a rare hap-
lotype in the disease chromosomes of subjects with CJD
from four Mediterranean countries and Chile strongly
suggests a common ancestral origin.
The Eastern European Haplotype
Microsatellite allele frequencies in the Slovakian un-
ambiguous 200K chromosomes were significantly dif-
ferent from the Slovakian population controls (P !
) for all three microsatellite markers tested (table.001
1), suggesting that a single ancestral chromosome is re-
sponsible for familial CJD in the Slovakian cluster. Con-
sensus haplotype 20-15-19 is seen much more frequently
(.70) than other possible haplotypes among the Slova-
kian 200K chromosomes or in Slovakian controls (table
2). This haplotype was found in 14 of 18 unambiguously
determined 200K chromosomes. The single family of
Polish origin shares the Slovakian consensus haplotype,
confirming that the 200K mutation in this family has a
common origin with the Slovakian cluster.
In an attempt to clarify the relationship between the
Mediterranean and eastern European 200K haplotypes,
we constructed and compared six-marker consensus
haplotypes (table 3). The unambiguous Libyan Jewish
chromosomes are divided between 18-28-20-14-18-13
(Libyan-1) and 21-28-20-14-19-19 (Libyan-2) haplo-
types that most likely drifted apart as a result of a double
recombination between D20S867 and D20S889, at the
telomeric end, and between D20S482 and D20S895, at
the centromeric end. The Tunisian Jewish mutated chro-
mosomes are also represented by two haplotypes, 18-
28-20-14-18-13 (Tunisian-1), which is identical to Lib-
yan-1, and 23-25-20-14-18-17 (Tunisian-2), which is
original. The Spanish haplotype is identical to Libyan-
1 and Tunisian-1. The Slovakian consensus haplotype
19-27-20-15-19-13 is different from any of the Medi-
terranean haplotypes in three of six alleles, suggesting
an independent origin. A disease haplotype distinct from
any of the preceding was found in a Japanese family
(tables 2 and 3).
The Western European Haplotypes
The unambiguous 200K mutation–associated micro-
satellite haplotype 19-13-23 in a family of German or-
Table 2
Microsatellite Three-Marker Haplotypes and PRNP 129M/V Polymorphism in the 200K-Associated and Control Chromosomes
HAPLOTYPE 200K-ASSOCIATED CHROMOSOMES CONTROL CHROMOSOMES
D20S116 D20S482 D20S895
Libyan Jews
(n  15)
Tunisian Jews
(n  6)
Italy
(n  6)
Chile
(n  6)
Spain
(n  1)
Slovakia
(n  23)
Poland
(n  1)
Japan
(n  1)
Germany
(n  1)
Sicily
(n  1)
Austria
(n  1)
Libyan
(n  43)
Slovakian
(n  92)
CEPH
(n  28)
18 13 18 ) ) ) ) ) ) ) ) ) ) ) ) ) )
18 13 19 .03 ) .00 ) ) .02 ) ) ) ) ) .03 .03 .06
18 13 21 ) ) ) .08 ) ) ) ) ) ) ) .02 ) )
18 13 22 ) ) ) ) ) ) ) .50 ) ) ) ) .01 )
18 13 23 ) ) ) ) ) ) ) .50 ) ) ) ) ) .04
18 14 18 ) ) .25 ) ) ) ) ) ) ) ) .04 ) )
18 14 19 ) ) ) .08 ) .09 ) ) ) ) ) .01 ) )
18 14 23 .06 ) ) ) ) ) ) ) ) .50 ) .01 .08 )
18 15 23 ) ) ) ) ) ) ) ) ) .50 ) .02 .03 )
19 12 25 ) ) ) ) ) .02 ) ) ) ) ) ) ) )
19 13 23 ) ) ) ) ) ) ) ) 1.00 ) ) .04 ) )
19 15 19 ) ) ) ) ) .02 ) ) ) ) ) ) ) )
20 13 18 ) ) ) ) ) ) ) ) ) ) ) ) .01 )
20 13 19 .03 ) .08 ) ) ) ) ) ) ) ) ) .03 .02
20 14 18 .47 1.00 .25 .42 1.00 ) ) ) ) ) ) ) .01 .02
20 14 19 .28 ) .08 ) ) .07 ) ) ) ) ) .14 .04 .03
20 14 21 .03 ) ) ) ) ) ) ) ) ) .13 .04 .04 .02
20 14 22 ) ) ) .08 ) ) ) ) ) ) ) .05 ) )
20 14 23 ) ) ) .08 ) ) ) ) ) ) .13 ) ) .08
20 14 27 ) ) .08 ) ) ) ) ) ) ) ) .04 ) )
20 15 19 ) ) ) ) ) .70 1.00 ) ) ) ) ) .05 .10
20 15 21 ) ) ) ) ) .04 ) ) ) ) .13 ) ) )
20 15 23 ) ) ) ) ) .02 ) ) ) ) .13 .02 ) .02
21 13 19 ) ) .08 ) ) ) ) ) ) ) ) ) ) )
21 13 23 ) ) ) .17 ) ) ) ) ) ) ) ) .05 .02
21 14 19 .03 ) ) ) ) .02 ) ) ) ) ) .13 .05 .05
21 14 21 ) ) ) ) ) ) ) ) ) ) .13 ) ) )
21 14 23 ) ) ) ) ) ) ) ) ) ) .13 .09 .01 )
21 15 21 ) ) ) ) ) ) ) ) ) ) .13 ) ) )
21 15 22 ) ) ) .08 ) ) ) ) ) ) ) ) ) )
21 15 23 ) ) .08 ) ) ) ) ) ) ) .13 ) ) )
22 14 19 .03 ) ) ) ) ) ) ) ) ) ) ) ) )
22 14 21 ) ) .08 ) ) ) ) ) ) ) ) .01 ) )
24 14 21 .03 ) ) ) ) ) ) ) ) ) ) .03 ) )
Other ) ) ) ) ) ) ) ) ) ) ) ) ) .28 .57 .53
PRNP 129M/V ) ) M M M M M M M M V V V M/V M/V M/V
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Table 3
Six-Marker Haplotypes in 200K Mutation–Associated Chromosomes from Mediterranean, Eastern
European, and Japanese Populations
MICROSATELLITE MARKER
HAPLOTYPE
NO. OF
FAMILIES D20S867 D20S889 D20S116 D20S482 D20S895 D20S849
Libyan -1 5 18 28 20 14 18 13
Libyan-2 2 21 28 20 14 19 19
Tunisian-1 3 18 28 20 14 18 13
Tunisian-2 2 23 25 20 14 18 17
Spanish 1 18 28 20 14 18 16
Slovakian 11 19 27 20 15 19 13
Japanese 1 18/22 22/24 18 13 22/23 16/20
igin is unique (table 2). The disease haplotypes in the
Sicilian and Austrian families are ambiguous, and it is
not clear whether they are related to the German hap-
lotype. In all three western European families, the 200K
mutation is coupled with GTG sequence coding for val-
ine at the PRNP polymorphic codon 129 (200K/129V
haplotype), in contrast to the Mediterranean, eastern
European, and Japanese CJD 200K chromosomes, with
129 ATG sequence coding for methionine (200K/129M
haplotype). Since the distance between the 200K mu-
tation and the polymorphic codon 129 is only 213 bp,
no recombination in this short fragment could be ex-
pected. Thus, the 200K chromosomes in patients from
Germany, Sicily, and Austria has an ancestral origin in-
dependent of the Mediterranean, eastern European, or
Japanese disease-associated chromosomes.
Discussion
Because of an unusually high prevalence in several
geographically distant clusters, the origin of the 200K
mutation has been a subject of interest. Our results show
that patients with CJD who originate from Libyan Jew-
ish and Tunisian Jewish populations, and from Spanish,
Italian, and Chilean non-Jewish populations all share
the 200K mutation–associated haplotype. The fact that
families affected by CJD, from five different geographic
locations, share a rare disease-associated haplotype sug-
gests that this haplotype has a common origin. We con-
cur with the first part of the hypothesis, presented else-
where, that the 200K mutation originated in the Iberian
Peninsula and spread to Mediterranean and South Amer-
ican countries, on the basis of the following historic
records. In 1492, the monarchs of Spain issued a decree
of expulsion of every Spanish Jew who refused to accept
Christianity. Two hundred thousand Jews moved to
North Africa, Turkey, France, Greece, Yugoslavia, Syria,
Palestine, Italy, and later to the Netherlands (Alpher
1986). Sephardim (the Spanish Jews) joined Jewish com-
munities that had existed in these areas for 11,000 years.
For many of the converted new Christians who remained
in Spain and Portugal, life was still insecure. Some of
them migrated to South American countries, including
Chile and Argentina, where their descendants are still
being remembered among the old Spanish families, as,
for example, the Medinas of Chile (Coon 1965). A Chil-
ean family affected with the 200K variant of familial
CJD was identified as progeny of 17th century Spanish
immigrants (Salvatore et al. 1996).
The presence of several 200K mutation–associated
Mediterranean haplotypes may correspond to a different
scenario. The Libyan-2 haplotype 20-14-19 is present in
the Libyan Jewish control population with a slightly
higher frequency than in other control populations, sug-
gesting that this may have been the ancient chromosome
on which the 200K mutation originally occurred. This
finding supports the previously expressed view that CJD
has been endemic in Libya longer than in other popu-
lations (Gabizon et al. 1993). The original Libyan-2 hap-
lotype may have been brought to Spain with the ancient
Jewish migrants and changed into the modern 20-14-18
haplotype as a result of a double recombination. This
newer haplotype has subsequently spread with the Mid-
dle Ages Sephardic migration to South America and the
Mediterranean countries including Libya. The Italian
population affected with the 200K variant of familial
CJD is not known to have Jewish roots, but the presence
of Sephardic communities in Italy in the Middle Ages
has been reported (Alpher 1986).
The eastern European 200K mutation–associated con-
sensus haplotype shows major differences from the Med-
iterranean haplotypes. The Slovakian families affected
with CJD living in a mountainous area of central Slo-
vakia are descendants of 13th–16th century immigrants
from Romania and Russia (Mitrova et al. 1991). On the
basis of haplotype analysis and historic data, the 200K
mutation in the Slovakian cluster had an origin different
from the 200K mutation that was spreading in the Med-
iterranean countries and South America. However, some
caution is needed, since the intragenic M/V polymor-
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phism at codon 129 of the PRNP gene used in this study
shows the presence of the same 129M allele in the Slo-
vakian and Mediterranean 200K mutation–associated
chromosomes. The origin of the German, Sicilian, and
Austrian 200K/129V haplotypes is definitely different
from either the Mediterranean or Slovakian haplotypes,
since they contain the alternative amino acid at position
129. The haplotype in the Japanese family is also unique.
A change from CG to TG is one of the most common
human mutations. Cytosine in the CpG dinucleotide se-
quence is known to be methylated frequently to produce
a 5-methylcytosine and these spontaneously deaminate
to thymine, resulting in a CrT transition (Bird 1980;
Cooper and Krawczak 1993).
We conclude from these data that at least four inde-
pendent mutational events are responsible for the current
geographic distribution of the 200K variant of heredi-
tary CJD. The 200K mutation of Spanish origin drifted
around the world with the migrating Sephardic popu-
lation. A similar historic and genetic analysis of the
world distribution of Machado-Joseph disease showed
a Portuguese founder haplotype that had spread to
France (Stevanin et al. 1995) and Japan (Takiyama et
al. 1995), whereas independent mutations have occurred
in the Algerian, Belgian, Guianese (Stevanin et al. 1995),
and Brazilian (Iughetti et al. 1996) populations.
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